Press Release Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights Last patient recruited in the NCX ...

The ocular hypertension market is growing due to the rising prevalence of conditions impairing aqueous humor outflow, such as scarring and inflammation, leading to elevated intraocular pressure (IOP).

No, Vaseline cannot make your eyelashes grow. However, some people may benefit from keeping their eyelashes hydrated, which ...

Press Release Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights Last patient recruited in the NCX 470 (bimatoprost grenod) Phase 3 Denali clinical trial with topline results ...

Read more. Sustained-release bimatoprost implant shows safety, efficacy in early study A sustained-release bimatoprost drug delivery platform shows promise in the treatment of ocular hypertension ...

When applied to your lash line on a daily basis, Latisse promotes the growth of lashes by extending the growth phase of the hair cycle. This, in turn, stimulates hair follicles and increases the ...

More than 3 million people in the U.S. are estimated to be living with glaucoma. By 2030, that number is expected to increase ...

GlobalData predicts that six late-stage pipeline products are set to enter the glaucoma market during the forecast period.

Durysta (bimatoprost implant) is a prescription medicine to reduce eye pressure in patients with glaucoma. With a quick office procedure, the Durysta implant can be inserted in the front chamber ...

Bimatoprost is under clinical development by Laboratoires Thea and currently in Phase III for Ocular Hypertension. According to GlobalData, Phase III drugs for Ocular Hypertension have a 75% phase ...